Ticker: AGLE

Company: Aeglea BioTherapeutics, Inc.

Person: Jeffrey W Albers, director

Transaction date: Nov. 6, 2024

Reporting date: Nov. 8, 2024

Average share price: 36.7631

Sold 6700.0 shares for 246312.77